Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma

American Journal of Hematology

Volumn 85, Issue 3, 2010, Pages 213-215

  Li, Yonghong ^a,b   Zheng, Tongzhang ^b   Kilfoy, Briseis A ^c   Lan, Qing ^c   Holford, Theodore ^b   Han, Xuesong ^b   Zhao, Ping ^d   Dai, Min ^d   Leaderer, Brian ^b   Rothman, Nat ^c   Zhang, Yawei ^b  

^a Institute for Environmental Health and Related Product Safety   (China)

^b YALE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE P1;

ADULT; AGED; ALCOHOL CONSUMPTION; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; ARYLAMINE N-ACETYLTRANSFERASE; BIOTRANSFORMATION; CARCINOGENS; CASE-CONTROL STUDIES; CONNECTICUT; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SMOKING; YOUNG ADULT;

EID: 77249162273     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21608     Document Type: Letter

References (30)

1. Chiu BC, Cerhan JR, Gapstur SM, et al. Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer 1999;80:1476-1482.
2. Morton LM, Zheng T, Holford TR, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: A pooled analysis. Lancet Oncol 2005;6:469-476.
3. Chiu BC, Weisenburger DD, Cantor KP,et al. Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men. Ann Epidemiol 2002;12:309-315.
4. Tavani A, Gallus S, La Vecchia C, Franceschi S. Alcohol drinking and risk of non-Hodgkin's lymphoma. Eur J Clin Nutr 2001;55:824-826.
5. Chang ET, Smedby KE, Zhang SM, et al. Alcohol intake and risk of non-Hodgkin lymphoma in men and women. Cancer Causes Control 2004;15:1067-1076.
6. Morton LM, Holford TR, Leaderer B, et al. Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control 2003;14:687-694.
7. Lim U, Morton LM, Subar AF, et al. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166:697-708.
8. Casey R, Piazzon-Fevre K, Raverdy N, et al. Case-control study of lymphoid neoplasm in three French areas: Description, alcohol and tobacco consumption. Eur J Cancer Prev 2007;16:142-150.
9. Monnereau A, Orsi L, Troussard X, et al. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: Results of a French case-control study. Cancer Causes Control 2008;19:1147-1160.
10. Polesel J, Dal Maso L, La Vecchia C, et al. Dietary folate, alcohol consumption, and risk of non-Hodgkin lymphoma. Nutr Cancer 2007;57:146-150.
11. Talamini R, Polesel J, Spina M, et al. The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer 2008;122:1624-1629.
12. Besson H, Brennan P, Becker N, et al. Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer 2006;119:901-908.
13. Sarmanová J,Benesová K, Gut I, et al. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001;10:1265-1273.
14. Gra OA, Glotov AS, Nikitin EA, et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 2008;83:279-287.
15. Skibola CF, Lightfoot T, Agana L, et al. Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma. Br J Haematol 2005;129:618-621.
16. Kerridge I, Lincz L, Scorgie F, et al. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002;118:477-481.
17. De Roos JA, Gold G, Wang S, et al. Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006;15:1647-1653.
18. Brian C-H, Chiu CK, Gapstur SM, et al. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: A population-based case-control study. Br J Haematol 2005;128:610-615.
19. Kilfoy BA, Zheng T, Lan Q, et al. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am J Hematol 2009;84:279-282.
20. Jaffe ES, Harris NL, Stein H, et al.Tumours of Haematopoietic and Lymphoid Tissues. Lyon:IARC press; 2001.
21. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: A public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32:D528-D532.
22. Hein DW. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002;506-507:65-77.
23. Cowpland C, Su GM, Murray M, et al. Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics. Clin Exp Pharmacol Physiol 2006;33:183-188.
24. Badger TM, Huang J, Ronis M, Lumpkin CK. Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP 2E1 gene when blood alcohol concentrations are high. Biochem Biophys Res Commun 1993;190:780-785.
25. Ronis MJ, Huang J, Crouch J, et al. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats. J Pharmacol Exp Ther 1993;264:944-950.
26. Ishikawa H, Miyatsu Y, Kurihara K, Yokoyama K. Gene-environmental interactions between alcohol-drinking behavior and ALDH2 and CYP2E1 polymorphisms and their impact on micronuclei frequency in human lymphocytes. Mutat Res 2006;594:1-9.
27. Thier R, Bruning T, Roos PH, Bolt HM. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer? Arch Toxicol 2002;76:249-256.
28. Yengi L, InskipA, Gilford J, et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996;56:1974-1977.
29. Bell DA, Badawi AF, Lang NP, et al. Polymorphism in theN-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allelewith higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995;55:5226-5229.
30. Hein DW, McQueen CA, Grant DM, et al. Pharmacogenetics of the arylamine N-acetyltransferases: A symposium in honor of Wendell W. Weber. Drug Metab Dispos 2000;28:1425-1432.